Gustave Roussy Research 🔬
@gr-research.bsky.social
Pioneering oncology research. Bridging fundamental, translational, and clinical research to advance precision medicine. 👩🔬👨🔬
🔗 www.gustaveroussy.fr
🔗 www.gustaveroussy.fr
New data in pancreatic #cancer!
The NEOPAN Phase III trial led by Prof. Michel Ducreux (@gustaveroussy.fr) shows FOLFIRINOX improves PFS vs gemcitabine in LAPC, with similar OS and QoL.
👉 doi.org/10.1200/JCO-...
#PancreaticCancer #OncoResearch #FOLFIRINOX
The NEOPAN Phase III trial led by Prof. Michel Ducreux (@gustaveroussy.fr) shows FOLFIRINOX improves PFS vs gemcitabine in LAPC, with similar OS and QoL.
👉 doi.org/10.1200/JCO-...
#PancreaticCancer #OncoResearch #FOLFIRINOX
May 28, 2025 at 7:06 AM
New data in pancreatic #cancer!
The NEOPAN Phase III trial led by Prof. Michel Ducreux (@gustaveroussy.fr) shows FOLFIRINOX improves PFS vs gemcitabine in LAPC, with similar OS and QoL.
👉 doi.org/10.1200/JCO-...
#PancreaticCancer #OncoResearch #FOLFIRINOX
The NEOPAN Phase III trial led by Prof. Michel Ducreux (@gustaveroussy.fr) shows FOLFIRINOX improves PFS vs gemcitabine in LAPC, with similar OS and QoL.
👉 doi.org/10.1200/JCO-...
#PancreaticCancer #OncoResearch #FOLFIRINOX
🚨Few days left!
Join us this Friday, May 16 at 13:30 (Paris time) for a deep dive into computational methods for spatial omics analyses.
🔍 Discover how Sopa and Novae, two open-source powerfool tools for spatial transcriptomics research.
⬇
Join us this Friday, May 16 at 13:30 (Paris time) for a deep dive into computational methods for spatial omics analyses.
🔍 Discover how Sopa and Novae, two open-source powerfool tools for spatial transcriptomics research.
⬇
May 13, 2025 at 12:56 PM
🚨Few days left!
Join us this Friday, May 16 at 13:30 (Paris time) for a deep dive into computational methods for spatial omics analyses.
🔍 Discover how Sopa and Novae, two open-source powerfool tools for spatial transcriptomics research.
⬇
Join us this Friday, May 16 at 13:30 (Paris time) for a deep dive into computational methods for spatial omics analyses.
🔍 Discover how Sopa and Novae, two open-source powerfool tools for spatial transcriptomics research.
⬇
📰 New ERN-EuroBloodNet guidelines for adult Burkitt lymphoma now published in The Lancet Haematology. First EU-wide recommendations to harmonise diagnosis, risk-adapted treatment & prognosis.
🔗 doi.org/10.1016/S235...
#Lymphoma #Haematology
🔗 doi.org/10.1016/S235...
#Lymphoma #Haematology
April 3, 2025 at 1:21 PM
📰 New ERN-EuroBloodNet guidelines for adult Burkitt lymphoma now published in The Lancet Haematology. First EU-wide recommendations to harmonise diagnosis, risk-adapted treatment & prognosis.
🔗 doi.org/10.1016/S235...
#Lymphoma #Haematology
🔗 doi.org/10.1016/S235...
#Lymphoma #Haematology
📢 New publication from @gustaveroussy.fr researchers & collaborators in Nature Cancer further supports the tumor-agnostic indication of pembrolizumab ! 📢
Read the study: doi.org/10.1038/s430...
Read the study: doi.org/10.1038/s430...
March 26, 2025 at 3:13 PM
📢 New publication from @gustaveroussy.fr researchers & collaborators in Nature Cancer further supports the tumor-agnostic indication of pembrolizumab ! 📢
Read the study: doi.org/10.1038/s430...
Read the study: doi.org/10.1038/s430...
📰 Low-dose gut radiation enhances immunotherapy.
New #research shows it boosts PD-L1 blockade, triggering a stronger systemic anti-tumor immune response. The gut microbiome plays a key role—this could be a game-changer for #cancer treatment.
#Immunotherapy #Oncology #PDL1
New #research shows it boosts PD-L1 blockade, triggering a stronger systemic anti-tumor immune response. The gut microbiome plays a key role—this could be a game-changer for #cancer treatment.
#Immunotherapy #Oncology #PDL1
March 19, 2025 at 2:43 PM
📰 Low-dose gut radiation enhances immunotherapy.
New #research shows it boosts PD-L1 blockade, triggering a stronger systemic anti-tumor immune response. The gut microbiome plays a key role—this could be a game-changer for #cancer treatment.
#Immunotherapy #Oncology #PDL1
New #research shows it boosts PD-L1 blockade, triggering a stronger systemic anti-tumor immune response. The gut microbiome plays a key role—this could be a game-changer for #cancer treatment.
#Immunotherapy #Oncology #PDL1
📰 “De-escalation in Lung Cancer Treatment: Are We Ready?”
A new review in JCO explores de-escalation strategies for ICBs in NSCLC—reducing dose, duration, or frequency—to cut toxicity, costs, and improve global access without compromising efficacy.
🔗 ascopubs.org/doi/full/10....
A new review in JCO explores de-escalation strategies for ICBs in NSCLC—reducing dose, duration, or frequency—to cut toxicity, costs, and improve global access without compromising efficacy.
🔗 ascopubs.org/doi/full/10....
March 13, 2025 at 10:46 AM
📰 “De-escalation in Lung Cancer Treatment: Are We Ready?”
A new review in JCO explores de-escalation strategies for ICBs in NSCLC—reducing dose, duration, or frequency—to cut toxicity, costs, and improve global access without compromising efficacy.
🔗 ascopubs.org/doi/full/10....
A new review in JCO explores de-escalation strategies for ICBs in NSCLC—reducing dose, duration, or frequency—to cut toxicity, costs, and improve global access without compromising efficacy.
🔗 ascopubs.org/doi/full/10....
Congrès IFODS 2025 🚀
📅 Le 12/06/2025, lors du Congrès National d’Oncologie - IFODS, nous vous donnons rendez-vous pour une session Présidentielle : IFODS - Gustave Roussy », qui se déroulera sous la présidence de Fabrice Barlesi, Francoise Mornex et Jean-Philippe SPANO. ⤵
📅 Le 12/06/2025, lors du Congrès National d’Oncologie - IFODS, nous vous donnons rendez-vous pour une session Présidentielle : IFODS - Gustave Roussy », qui se déroulera sous la présidence de Fabrice Barlesi, Francoise Mornex et Jean-Philippe SPANO. ⤵
March 11, 2025 at 8:51 AM
Congrès IFODS 2025 🚀
📅 Le 12/06/2025, lors du Congrès National d’Oncologie - IFODS, nous vous donnons rendez-vous pour une session Présidentielle : IFODS - Gustave Roussy », qui se déroulera sous la présidence de Fabrice Barlesi, Francoise Mornex et Jean-Philippe SPANO. ⤵
📅 Le 12/06/2025, lors du Congrès National d’Oncologie - IFODS, nous vous donnons rendez-vous pour une session Présidentielle : IFODS - Gustave Roussy », qui se déroulera sous la présidence de Fabrice Barlesi, Francoise Mornex et Jean-Philippe SPANO. ⤵
🚀 Join us at the inaugural AI in Oncology 2025 Conference ! 🚀
📅 June 17-18, 2025
📍 Paris, France
🌍 Bringing together top researchers, clinicians, and industry leaders
🔗 Register now and be part of the conversation: www.aiinoncology.com
📅 June 17-18, 2025
📍 Paris, France
🌍 Bringing together top researchers, clinicians, and industry leaders
🔗 Register now and be part of the conversation: www.aiinoncology.com
March 5, 2025 at 2:21 PM
🚀 Join us at the inaugural AI in Oncology 2025 Conference ! 🚀
📅 June 17-18, 2025
📍 Paris, France
🌍 Bringing together top researchers, clinicians, and industry leaders
🔗 Register now and be part of the conversation: www.aiinoncology.com
📅 June 17-18, 2025
📍 Paris, France
🌍 Bringing together top researchers, clinicians, and industry leaders
🔗 Register now and be part of the conversation: www.aiinoncology.com